Investing Profile

Florian Müllershausen

InvestorVC
Managing Director at Novartis Venture Fund
nvfund.comBasel, Switzerland
Photo of Florian Müllershausen, Managing Director at Novartis Venture Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Novartis Venture Fund Managing Director
$5.0M - $10.0M
$7.5M
7
$750M
CompanyStageDateRound SizeTotal Raised
LOQUS23 THERAPEUTICS
Series AOct 2024$47M
SeedNov 2021$9M
$56M
Co-investors: Rogier Rooswinkel (Forbion)
Artios Pharma
Series CJul 2021$150M
Series BAug 2018$83M
$270M
Co-investors: René Kuijten (EQT Life Sciences), Raphael Wisniewski (Andera Partners), Barbara Dalton (Pfizer Venture Investments), Hakan Goker (M Ventures (Merck))
Amphista Therapeutics
Series BMar 2021$53M
$61M
Co-investors: Satish Jindal (Advent Life Sciences), Raj Parekh (Advent Life Sciences), Rogier Rooswinkel (Forbion)
FoRx Therapeutics
SeedApr 2020$11M
$11M
Co-investors: Denis Patrick (Pfizer Venture Investments), Therese Liechtenstein (M Ventures (Merck)), Vincent Ossipow (Omega Funds), Vincent Brichard
Anaveon
Series AFeb 2019$35M
$160M
Co-investors: Ohad Hammer (Pontifax Venture Capital), Jasper Bos (Forbion), Denis Patrick (Pfizer Venture Investments)
Ruhr University Bochum Dr. rer. nat. (PhD)
Freie Universität Berlin Diploma (eq. to MSc